STOCHASTIC (Class 99)

The trademark application number 8097428 is currently marked as "Ready for Examination" in the official trademark registry.

The trademark application number 8097428 is owned by POPVAX PRIVATE LIMITED.

Trademark application number 8097428 is filed under Class 99, which relates to the specified goods and services.

The trademark agent associated with application number 8097428 is SUDESHNA BANERJEE[21065].

Trademark application number 8097428 relates to "[CLASS : 9] Software relating to healthcare, disease management; Software related to management of health or disease; Software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; Software for creating, managing, analyzing, and processing data related to research, development, and manufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of healthcare, disease management; Software for controlling, optimization, calibration, maintenance, diagnostics, and troubleshooting of bioprocess systems, equipments, tools, and apparatus namely mixing devices, microfluidic devices, micro-mixing devices, mixing vessels, filtration systems, fermenters or bioreactors, liquid handling systems, separation systems, purification systems, chromatography systems, formulation systems, analytical systems, characterization systems, filling system, lyophilisation system, spray drying system, encapsulation system, pumps, pressure vessels, sensors, actuators, flow controllers, control system for fluidics, automated control systems, robotic systems, synthesis systems, and thermocyclers; Software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, analytical characterization, immunological assays, and neutralization assays for production or manufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of healthcare, disease management; pre-recorded audio-visual or multimedia products in the nature of cassettes, audiotapes, videotapes, CDs, DVDs, CD-ROMs, pre-recorded optical discs, and portable storage devices in the field of healthcare, disease management, pharmaceuticals and medical developments; Podcasts in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics and biosimilars; Chromatography apparatus for laboratory use; bioreactors for laboratory and research use; computer software for the programming and simulation of industrial robots; computer programs for the control of industrial robots; computer software for the programming and operation of automated machines; computer software platform powered by artificial intelligence and deep learning for predictive analysis in the field of biological research, medical research, pharmaceutical research, and drug discovery; computer software powered by artificial intelligence and machine learning for analysing research data, scientific data, biomedical data, clinical data, and simulating biochemical interactions; computer software using artificial intelligence and machine learning for molecular modelling, protein structure prediction, drug interactions, and drug discovery; robots for use in scientific research; controllers and regulators for robotics; integrated circuits and microprocessors for robotic automation systems; computer software for controlling robots; computer software for laboratory automation and data analysis. [CLASS : 42] Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; clinical trials and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; Software as a service (SaaS); Platform as a service (PaaS); creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring information in the pharmaceutical, medical and health fields; hosting podcasts; Software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; Software as a service (SaaS) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management; Software as a service (SaaS) services featuring computer software utilizing artificial intelligence and machine learning for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; Software as a service (SaaS) services featuring computer software utilizing artificial intelligence and machine learning for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management; software development; Software as a service (SaaS) services featuring computer software platforms utilizing artificial intelligence and machine learning for screening chemical compounds, predicting drug toxicity, and clinical trial data analysis; Platform as a service (Paas) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; Artificial intelligence as a services (AiaaS) for pharmaceutical and biological research.".